Translate

Πέμπτη 5 Μαρτίου 2020


Some Rare Neuroendocrine Tumors May Respond to Ipilimumab Plus Nivolumab Some Rare Neuroendocrine Tumors May Respond to Ipilimumab Plus Nivolumab
Patients with fast-growing non-pancreatic neuroendocrine tumors may respond to combination therapy with ipilimumab plus nivolumab, according to findings within the Dual Anti-CTLA-4& Anti-PD-1 blockade in Rare Tumors (DART) trial.Reuters Health Information (Source: Medscape Allergy Headlines)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 22:36
Radiation Treatments Need to Take Breast Size Into Account: Study
(Source: The Doctors Lounge - Oncology)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 21:00
Omega - 3 Fatty Acids Seem Not to Protect Against Cancer
And, limited cardiovascular benefit found for long chain omega - 3, alpha - linolenic acid (Source: The Doctors Lounge - Oncology)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 19:00
Chemotherapy after surgery halves risk of rare kidney cancer coming back
(Institute of Cancer Research) Chemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in the disease worldwide has found.Patients given chemotherapy within three months of surgery saw the risk of their cancer coming back or spreading reduced and were much more likely to live cancer free for three years or more. (Source: EurekAlert! - Cancer)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
HSD3B1 May Be Associated with Earlier Castration Resistance, Shorter OS in Prostate Cancer
HSD3B1 may help identify more men who are likely to benefit from escalated androgen receptor axis inhibition beyond gonadal testosterone suppression according to the researchers. (Source: CancerNetwork)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
Artificial Intelligence to improve the precision of mammograms
(Universitat Polit è cnica de Val è ncia) The Artificial Intelligence techniques, used in combination with evaluations by expert radiologists, improve the precision in the detection of cancer through mammograms. This is one of the main conclusions of an international study, in which researchers from the Universitat Polit è cnica de Val è ncia (UPV), CSIC and the Universitat de Val è ncia have participated, and has been published in one of the most widely distributed medical journals, the Journal...
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
(Cell Press) A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses. The work appears March 5 in the journal Cell. (Source: EurekAlert! - Cancer)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
New drug combination could support better cancer treatments
(University of Queensland) Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them. (Source: EurekAlert! - Cancer)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHD
Madan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib. (Source: CancerNetwork)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
Lower Risk of Melanoma Diagnosis and Increased Mortality Following Partner Bereavement
These findings highlight the need to raise public awareness of the importance of self-skin examination, and to encourage clinicians to have a lower threshold for undertaking skin examinations in bereaved individuals, according to the researchers. (Source: CancerNetwork)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
Statins Associated with Lower All-Cause and Prostate Cancer Mortality
The use of statins, alone or in combination with metformin, was found to be associated with lower all-cause and prostate cancer mortality among high-risk patients, particularly in post-diagnostic settings. (Source: CancerNetwork)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
Native Americans and higher cigarette use: Stereotype goes up in smoke
(University of Arizona Health Sciences) University of Arizona Health Sciences study finds when whites and Native Americans in comparable income and education levels are compared, whites consume more cigarettes and are more nicotine dependent. Results published in the journal Drug and Alcohol Dependence. (Source: EurekAlert! - Cancer)
MedWorm Cancer & Oncology News
Thu Mar 05, 2020 06:00
City of Hope creates innovative platform for landmark study, opening data to more people
(City of Hope) A $12 million federal grant enabled City of Hope and collaborators to deploy a novel cloud-computing platform, making an immense amount of data from a historic 25-year study more accessible and user-friendly. The ongoing California Teachers Study that first began in 1995 has already given researchers a bevy of data on how to prevent or treat cancers, heart conditions and Alzheimer's disease. In the past, this data was available only to a select few researchers. (Source: EurekAlert!...
MedWorm Cancer & Oncology News
Wed Mar 04, 2020 06:00
IJMS, Vol. 21, Pages 1803: Polymer Stabilized Cholesteric Liquid Crystal Siloxane for Temperature-Responsive Photonic Coatings
IJMS, Vol. 21, Pages 1803: Polymer Stabilized Cholesteric Liquid Crystal Siloxane for Temperature-Responsive Photonic Coatings International Journal of Molecular Sciences doi: 10.3390/ijms21051803 Authors: Weixin Zhang Johan Lub Albertus P.H.J. Schenning Guofu Zhou Laurens T. de Haan Temperature-responsive photonic coatings are appealing for a variety of applications, including smart windows. However, the fabrication of such reflective polymer coatings remains a...
International Journal of Molecular Sciences
02:00
Κορωνοϊός: Τι να προσέχετε από όσα διαβάζετε στο διαδίκτυο
Η εξάπλωση του κορωνοϊού σε όλον τον κόσμο και ειδικότερα στην Ελλάδα, είναι λογικό να συνοδεύεται από ορυμαγδό πληροφοριών και συμβουλών για το τι πρέπει να κάνουμε ή να μην κάνουμε, για να προστατευθούμε. The post Κορωνοϊός: Τι να προσέχετε από όσα διαβάζετε στο διαδίκτυο appeared first on Iatropedia.
Iatropedia.gr
08:01
Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study
Abstract Background Third-line antidiabetic drug (ADD) intensification patterns and glycemic control post intensification in type 2 diabetes mellitus (T2DM) have not been thoroughly explored in a real-world setting. Objective This study explored the patterns and risks of third-line ADD intensification post second-line ADDs and the probability of desirable...
Latest Results for Drugs
02:00
Results from extended lymphadenectomies with [ 111 In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
Abstract Purpose Identification of suspicious PSMA-PET/CT-positive lymph node (LN) metastases (LNM) from prostate cancer (PCa) during lymphadenectomy (LA) is challenging. We evaluated an 111In-labelled PSMA ligand (DKFZ-617, referred to as [111In]PSMA-617) as a γ-emitting tracer for intraoperative γ-probe application for resected tissue samples in PCa patients. Forty-eight hours prior to LA, [111In]PSMA-617 was administered intravenously...
Latest Results for EJNMMI Research
02:00
Kinetic modeling of 68 Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients
Abstract Background The positron emission tomography (PET) ligand 68Ga-Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11) targets the prostate-specific membrane antigen (PSMA), upregulated in prostate cancer cells. Although 68Ga-PSMA-11 PET is widely used in research and clinical practice, full kinetic modeling has not yet been reported nor have simplified methods for quantification been validated. The aims of our study were to quantify...
Latest Results for EJNMMI Research
Mon Feb 24, 2020 02:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου

Translate